Cite

HARVARD Citation

    Ball, R. et al. (n.d.). The FDA's sentinel initiative—A comprehensive approach to medical product surveillance. Clinical pharmacology & therapeutics. 99 (3), pp. 265-268. [Online]. 
  
Back to record